Clinical Trials Logo

Clinical Trial Summary

This is a trial of up to 6-months duration for safety, tolerability, clinical efficacy assessments, PK and biomarkers analysis in breast carcinoma patients with secondary lymphoedema


Clinical Trial Description

This trial will utilize a randomised, double-blinded, placebo controlled design that will assess the safety, tolerability, and secondarily clinical efficacy of LYT-100 over a period of up to 6-months of dosing in breast carcinoma patients with secondary lymphoedema following sentinel lymph node biopsy and/or axillary node dissection, with or without radiation. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04243837
Study type Interventional
Source PureTech
Contact
Status Terminated
Phase Phase 2
Start date March 1, 2020
Completion date September 9, 2022

See also
  Status Clinical Trial Phase
Completed NCT01864044 - Prospective Observational Lymphoedema Intensive Treatment
Completed NCT01152099 - A Clinical Trial About the Contribution of Manual Lymph Drainage in Complex Physical Therapy for Patients With Lymphoedema Secondary to Mastectomy N/A
Completed NCT00215280 - Epidemiology and Control of Mansonella Perstans Infection in Uganda N/A
Completed NCT05169086 - Comparison of Two Types of Bandages in the Treatment of Lymphoedema
Completed NCT03825263 - Intermittent Pneumatic Compression for Treating Lower Limb Lymphoedema N/A
Recruiting NCT03580109 - Spa Therapy for Upper or Lower Limb Lymphoedema N/A
Completed NCT02015897 - Effect of Physical Therapy on Breast Cancer Related Lymphedema N/A
Completed NCT02476357 - A Study for Lymphocele and Lymphorrhea Control Following Inguinal and Axillary Radical Lymph Node Dissection N/A